Literature DB >> 16043718

Disabling TNF receptor signaling by induced conformational perturbation of tryptophan-107.

Ramachandran Murali1, Xin Cheng, Alan Berezov, Xiulian Du, Arnie Schön, Ernesto Freire, Xiaowei Xu, Youhai H Chen, Mark I Greene.   

Abstract

We have disabled TNF receptor (TNFR) function by inducing allosteric modulation of tryptophan-107 (W107) in the receptor. The allosteric effect operates by means of an allosteric cavity found a short distance from a previously identified loop involved in ligand binding. Occupying this cavity by small molecules leads to perturbation of distal W107 and disables functions of the TNFR, a molecule not known to undergo conformational change upon binding TNF-alpha. TNF-alpha-induced NF-kappaB and p38 kinase activities and clinical symptoms of collagen-induced arthritis in mice were all diminished. Thus, disabling receptor function by induced conformational changes of active binding surfaces represents an innovative paradigm in structure-based drug design.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043718      PMCID: PMC1182441          DOI: 10.1073/pnas.0504301102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity.

Authors:  L R Hoffman; I D Kuntz; J M White
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Flexibility of human IgG subclasses.

Authors:  K H Roux; L Strelets; T E Michaelsen
Journal:  J Immunol       Date:  1997-10-01       Impact factor: 5.422

3.  A ligand-gated, hinged loop rearrangement opens a channel to a buried artificial protein cavity.

Authors:  M M Fitzgerald; R A Musah; D E McRee; D B Goodin
Journal:  Nat Struct Biol       Date:  1996-07

4.  Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor.

Authors:  W Takasaki; Y Kajino; K Kajino; R Murali; M I Greene
Journal:  Nat Biotechnol       Date:  1997-11       Impact factor: 54.908

5.  Direct measurement of small ligand-induced conformational changes in the aspartate chemoreceptor using EPR.

Authors:  K M Ottemann; T E Thorgeirsson; A F Kolodziej; Y K Shin; D E Koshland
Journal:  Biochemistry       Date:  1998-05-19       Impact factor: 3.162

6.  Identification of a loop outside the active site cavity of the human immunodeficiency virus proteases which confers inhibitor specificity.

Authors:  E M Towler; S K Thompson; T Tomaszek; C Debouck
Journal:  Biochemistry       Date:  1997-04-29       Impact factor: 3.162

7.  Distal cavity fluctuations in myoglobin: protein motion and ligand diffusion.

Authors:  M L Carlson; R M Regan; Q H Gibson
Journal:  Biochemistry       Date:  1996-01-30       Impact factor: 3.162

8.  Agonist-independent effect of an allosteric enhancer of the A1 adenosine receptor in CHO cells stably expressing the recombinant human A1 receptor.

Authors:  C A Kollias-Baker; J Ruble; M Jacobson; J K Harrison; M Ozeck; J C Shryock; L Belardinelli
Journal:  J Pharmacol Exp Ther       Date:  1997-05       Impact factor: 4.030

9.  Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor.

Authors:  J H Naismith; T Q Devine; B J Brandhuber; S R Sprang
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

10.  Characterization of tryptophan environments in glutamate dehydrogenases from temperature-dependent phosphorescence.

Authors:  G B Strambini; P Cioni; R A Felicioli
Journal:  Biochemistry       Date:  1987-08-11       Impact factor: 3.162

View more
  11 in total

1.  Noncompetitive inhibitors of TNFR1 probe conformational activation states.

Authors:  Chih Hung Lo; Tory M Schaaf; Benjamin D Grant; Colin Kin-Wye Lim; Prachi Bawaskar; Courtney C Aldrich; David D Thomas; Jonathan N Sachs
Journal:  Sci Signal       Date:  2019-07-30       Impact factor: 8.192

2.  Disabling the mitotic spindle and tumor growth by targeting a cavity-induced allosteric site of survivin.

Authors:  A Berezov; Z Cai; J A Freudenberg; H Zhang; X Cheng; T Thompson; R Murali; M I Greene; Q Wang
Journal:  Oncogene       Date:  2011-09-05       Impact factor: 9.867

3.  Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis.

Authors:  Sandra J Saouaf; Bin Li; Geng Zhang; Yuan Shen; Narumi Furuuchi; Wayne W Hancock; Mark I Greene
Journal:  Exp Mol Pathol       Date:  2009-07-03       Impact factor: 3.362

4.  Structural basis for treating tumor necrosis factor α (TNFα)-associated diseases with the therapeutic antibody infliximab.

Authors:  Shuaiyi Liang; Jianxin Dai; Sheng Hou; Lishu Su; Dapeng Zhang; Huaizu Guo; Shi Hu; Hao Wang; Zihe Rao; Yajun Guo; Zhiyong Lou
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

5.  Ainsliadimer A selectively inhibits IKKα/β by covalently binding a conserved cysteine.

Authors:  Ting Dong; Chao Li; Xing Wang; Longyang Dian; Xiuguo Zhang; Lin Li; She Chen; Ran Cao; Li Li; Niu Huang; Sudan He; Xiaoguang Lei
Journal:  Nat Commun       Date:  2015-03-27       Impact factor: 14.919

6.  Novel TNF receptor-1 inhibitors identified as potential therapeutic candidates for traumatic brain injury.

Authors:  Rachel K Rowe; Jordan L Harrison; Hongtao Zhang; Adam D Bachstetter; David P Hesson; Bruce F O'Hara; Mark I Greene; Jonathan Lifshitz
Journal:  J Neuroinflammation       Date:  2018-05-22       Impact factor: 8.322

7.  Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer.

Authors:  James O'Connell; John Porter; Boris Kroeplien; Tim Norman; Stephen Rapecki; Rachel Davis; David McMillan; Tracy Arakaki; Alex Burgin; David Fox Iii; Tom Ceska; Fabien Lecomte; Alison Maloney; Alex Vugler; Bruce Carrington; Benjamin P Cossins; Tim Bourne; Alastair Lawson
Journal:  Nat Commun       Date:  2019-12-19       Impact factor: 14.919

8.  TCR Nanoclusters as the Framework for Transmission of Conformational Changes and Cooperativity.

Authors:  Raquel Blanco; Balbino Alarcón
Journal:  Front Immunol       Date:  2012-05-09       Impact factor: 7.561

Review 9.  Therapeutic potential of TNFα inhibitors in chronic inflammatory disorders: Past and future.

Authors:  Hongtao Zhang; Nelson Shi; Zhuo Diao; Youhai Chen; Yejia Zhang
Journal:  Genes Dis       Date:  2020-03-03

10.  Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth.

Authors:  Hirotaka Kanzaki; Avradip Chatterjee; Hanieh Hossein Nejad Ariani; Xinfeng Zhang; Stacey Chung; Nan Deng; V Krishnan Ramanujan; Xiaojiang Cui; Mark I Greene; Ramachandran Murali
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.